Crossmark

Factors associated with initiation and persistence of urate-lowering therapy

Crossref DOI link: https://doi.org/10.1186/s13075-016-1211-y

Published Online: 2017-01-17

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dehlin, Mats http://orcid.org/0000-0001-5165-0968
Ekström, Emin Hoxha

Petzold, Max

Strömberg, Ulf

Telg, Gunilla

Jacobsson, Lennart T. H.
Funding

Funding for this research was provided by:

AstraZeneca Nordic-Baltic